Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
STZ 1172 Gesundheitsförderung und Stoffwechselforschung is a specialized Steinbeis Transfer Center focused on metabolic research and the promotion of health through lifestyle and nutritional interventions. Located in Freiburg, Germany, the center serves as a bridge between academic clinical research and the healthcare industry, offering services such as clinical trial coordination, metabolic profiling, and performance diagnostics. Its expertise is primarily directed toward addressing metabolic syndrome, obesity, and type 2 diabetes. The center provides strategic consulting and scientific evaluation for pharmaceutical, food, and medical device companies. By leveraging its affiliation with the University of Freiburg, STZ 1172 facilitates the translation of scientific findings into practical health solutions and commercial products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on STZ 1172 Gesundheitsförderung und Stoffwechselforschung.